Interventions Study for the Control of Diabetes Mellitus Type 2 in Obese Women
Phase 4
45 Years
N/A
45 Years
N/A
Not Enrolling
Female
Diabetes Mellitus, Type 2
Female
Diabetes Mellitus, Type 2
Trial Information
Interventions Study for the Control of Diabetes Mellitus Type 2 in Obese Women
Inclusion Criteria:
- Menopausal
- Diagnosed diabetes mellitus type 2
- Obese (body mass index [BMI] > 25 ≤ 30)
Exclusion Criteria:
- Fasting blood glucose ≥ 200 mg/dl
- CRP < 2 mg/L and > 10 mg/L
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Outcome Measure:
Patients will be receiving rosuvastatin/placebo for 6 months
Principal Investigator
Astra Zeneca Mexico Medical Director, MD
Investigator Role:
Study Director
Investigator Affiliation:
AstraZeneca
Authority:
Mexico: Federal Commission for Protection Against Health Risks
Study ID:
DM-CRESTOR-0001
NCT ID:
NCT00262548
Start Date:
October 2005
Completion Date:
Related Keywords:
- Diabetes Mellitus, Type 2
- Obesity
- Menopause
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
Name | Location |
|---|
